Both in Pharmaceuticals
Latigo Biotherapeutics vs Kura Oncology
Over the past year LTGO returned −38.1% and KURA returned −13.4%; their daily moves had a correlation of 0.51.
LTGO −38.1% KURA −13.4%Growth of $1, one year, split-adjusted
| Metric | LTGO | KURA |
|---|---|---|
| Price | $13.72 | $9.86 |
| Market cap | $909.3M | $877.2M |
| Today | −1.68% | −3.90% |
| 1 month | −13.7% | −7.4% |
| 6 months | — | +6.6% |
| Year to date | — | −5.1% |
| 1 year | — | −5.6% |
| Revenue growth (YoY) | — | +36.5% |
| Gross margin | — | 98.8% |
| Net margin | — | −327.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 11.4× |
| Net cash | — | $509.2M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.8% |
| Short % of float | 1.6% | 18.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).